Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Lysine-Targeting Reversible Covalent Inhibitors with Long Residence Time
Rahi M. Reja, Wenjian Wang, Yuhan Lyu, et al.
Journal of the American Chemical Society (2022) Vol. 144, Iss. 3, pp. 1152-1157
Open Access | Times Cited: 73

Showing 1-25 of 73 citing articles:

Emerging and Re-emerging Warheads for Targeted Covalent Inhibitors: An Update
Laura Hillebrand, Xiaojun Julia Liang, Ricardo A. M. Serafim, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 10, pp. 7668-7758
Closed Access | Times Cited: 49
An update on the discovery and development of reversible covalent inhibitors
Faridoon Faridoon, Raymond Ng, Guiping Zhang, et al.
Medicinal Chemistry Research (2023) Vol. 32, Iss. 6, pp. 1039-1062
Open Access | Times Cited: 46
Multiple redox switches of the SARS-CoV-2 main protease in vitro provide opportunities for drug design
Lisa-Marie Funk, Gereon Poschmann, Fabian Rabe von Pappenheim, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 16
Lysine-Targeted Reversible Covalent Ligand Discovery for Proteins via Phage Display
Mengmeng Zheng, Fa‐Jie Chen, Kaicheng Li, et al.
Journal of the American Chemical Society (2022) Vol. 144, Iss. 34, pp. 15885-15893
Open Access | Times Cited: 50
Click chemistry and drug delivery: A bird's-eye view
Shameer M. Kondengadan, Shubham Bansal, Ce Yang, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 13, Iss. 5, pp. 1990-2016
Open Access | Times Cited: 50
Thiomethyltetrazines Are Reversible Covalent Cysteine Warheads Whose Dynamic Behavior can be “Switched Off” via Bioorthogonal Chemistry Inside Live Cells
Amanda Tallon, Yingrong Xu, Graham M. West, et al.
Journal of the American Chemical Society (2023) Vol. 145, Iss. 29, pp. 16069-16080
Closed Access | Times Cited: 25
Development of covalent inhibitors: Principle, design, and application in cancer
Lang Zheng, Yang Li, Defa Wu, et al.
MedComm – Oncology (2023) Vol. 2, Iss. 4
Open Access | Times Cited: 25
A pyridinium-based strategy for lysine-selective protein modification and chemoproteomic profiling in live cells
Chuan Wan, Dongyan Yang, Chunli Song, et al.
Chemical Science (2024) Vol. 15, Iss. 14, pp. 5340-5348
Open Access | Times Cited: 11
Biospecific Chemistry for Covalent Linking of Biomacromolecules
Li Cao, Lei Wang
Chemical Reviews (2024) Vol. 124, Iss. 13, pp. 8516-8549
Open Access | Times Cited: 11
Peptide‐based covalent inhibitors of protein–protein interactions
Felix M. Paulussen, Tom N. Grossmann
Journal of Peptide Science (2022) Vol. 29, Iss. 1
Open Access | Times Cited: 32
Applications of covalent chemistry in targeted protein degradation
Dong Lu, Xin Yu, Hanfeng Lin, et al.
Chemical Society Reviews (2022) Vol. 51, Iss. 22, pp. 9243-9261
Open Access | Times Cited: 29
How many kinases are druggable? A review of our current understanding
Brian Anderson, Peter Rosston, Han Wee Ong, et al.
Biochemical Journal (2023) Vol. 480, Iss. 16, pp. 1331-1363
Open Access | Times Cited: 21
The expanding repertoire of covalent warheads for drug discovery
Namrashee V. Mehta, Mariam S. Degani
Drug Discovery Today (2023) Vol. 28, Iss. 12, pp. 103799-103799
Closed Access | Times Cited: 20
Biomimetic Synthesis and Chemical Proteomics Reveal the Mechanism of Action and Functional Targets of Phloroglucinol Meroterpenoids
Amy K. Bracken, Colby E. Gekko, Nina O. Suss, et al.
Journal of the American Chemical Society (2024) Vol. 146, Iss. 4, pp. 2524-2548
Open Access | Times Cited: 7
Reversible Covalent Inhibition─Desired Covalent Adduct Formation by Mass Action
Disha Patel, Zil E Huma, Dustin Duncan
ACS Chemical Biology (2024) Vol. 19, Iss. 4, pp. 824-838
Open Access | Times Cited: 7
Protein–protein interactions: developing small-molecule inhibitors/stabilizers through covalent strategies
Bobby Lucero, Karol R. Francisco, Lawrence J. Liu, et al.
Trends in Pharmacological Sciences (2023) Vol. 44, Iss. 7, pp. 474-488
Open Access | Times Cited: 15
Conversion of albumin into a BODIPY-like photosensitizer by a flick reaction, tumor accumulation and photodynamic therapy
Mengyao Yang, Yu-Jin Kim, So-Yeon Youn, et al.
Biomaterials (2024) Vol. 313, pp. 122792-122792
Closed Access | Times Cited: 5
Reactivity of Covalent Fragments and Their Role in Fragment Based Drug Discovery
Kirsten McAulay, Alan Bilsland, Marta Bon
Pharmaceuticals (2022) Vol. 15, Iss. 11, pp. 1366-1366
Open Access | Times Cited: 22
Tailored Chemical Reactivity Probes for Systemic Imaging of Aldehydes in Fibroproliferative Diseases
Hua Ma, Iris Y. Zhou, Y Iris Chen, et al.
Journal of the American Chemical Society (2023) Vol. 145, Iss. 38, pp. 20825-20836
Open Access | Times Cited: 12
Recent progress of chemical methods for lysine site-selective modification of peptides and proteins
Jian Li, Jinjin Chen, Qi-Long Hu, et al.
Chinese Chemical Letters (2024), pp. 110126-110126
Closed Access | Times Cited: 4
Nanozymes with Modulable Inhibition Transfer Pathways for Thiol and Cell Identification
Lijun Hu, Lei Jiao, Chengjie Chen, et al.
Analytical Chemistry (2025)
Closed Access
O-Cyanobenzaldehydes Irreversibly Modify Both Buried and Exposed Lysine Residues in Live Cells
Huan Ling, Lin Li, Liping Duan, et al.
Journal of the American Chemical Society (2025)
Closed Access
Recent highlights in covalent inhibitor design
Kristen A. Marino, Robert Nicewonger, Hailong Zhang, et al.
Elsevier eBooks (2025)
Closed Access
Covalent Solvatochromic Proteome Stress Sensor Based on the Schiff Base Reaction
Di Shen, Wenhan Jin, Qun Zhao, et al.
Analytical Chemistry (2022) Vol. 94, Iss. 41, pp. 14143-14150
Closed Access | Times Cited: 18
Advances in reversible covalent kinase inhibitors
Zheng Zhao, Philip E. Bourne
Medicinal Research Reviews (2024)
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top